#news #biotech Otsuka to acquire antibody developer Visterra in $430M deal

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Otsuka to acquire antibody developer Visterra in $430M deal .Otsuka Pharmaceutical plans to acquire previous Fierce 15 winner Visterra and its antibody engineering platform for $430 million in cash, as Otsuka looks to build out proprietary drug discovery and development efforts across its programs, including in nephrology and other difficult diseases.

from FierceBiotech: Biotech https://ift.tt/2KMwIVL